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Table S1, Effect of the substituent [R] with a fixed spacer length [n] = 3 of ligand 1 on the copper 
catalyzed asymmetric Diels-Alder Reaction of cyclopentadiene (2) with aza-chalcone (3) in the presence 
of salmon testes DNA under standard reaction conditions (experimental section). a) Average of at least 2 
experiments. Endo:exo ratio was determined by hplc, and confirmed by NMR analysis. E.e.’s were 
determined by hplc on an OD or ODH column. E.e values were reproducible within 1 % for the endo 
isomer and within 2-3 % for the exo product;  b) RT = room temperature; c) conditions: 0.6 mM catalyst, 
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Table S2, Control experiments. a) conversion 50-60 %. b) conversion < 5%. c) n.d. = not 
determined. d) quantitative conversion. e) conversion varies between 50-70 %, a slightly brown 





Figure S1, UV/Vis spectra. A) copper complex of 1a (solid line) and free ligand 1a (hashed line) 
without DNA; B)  copper complex of 1a (solid line), free ligand (hashed line) and Cu(NO3)2 
(dotted line) in the presence of salmon testes DNA (0.8 mg/ml). All solutions were buffered (20 
mM Mops, pH 6.5), ligand and copper concentrations were 150 µM. 
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Experimental and Synthetic Procedures 
 
General remarks 
Salmon testes and calt thymus DNA were obtained from Sigma. Dienophiles 3a-c were prepared 
following published procedures.1 Cyclopentadiene (2) was freshly prepared from its dimer prior 
to use. Mono-boc protected diamines (5) were obtained from Fluka, or prepared following 
literature procedures.[2] 
 
Dissolution of synthetic oligonucleotide. 
The synthetic 16-mer d(GACT)2(AGTC)2 was obtained from Sigma-Genosys. The lyophilized 
powder was dissolved in buffer (20 mM Mops, 100 mM NaCl, pH 6.5), heated to 94 °C and 
slowly cooled to room temperature. After centrifugation the supernatant, containing the dissolved 
oligonucleotide, was decanted. Concentration was determined by UV/Vis, using ε260 = 31.3 
OD/µg. CD spectroscopy showed the features typical for right-handed helical B-form DNA, i.e. a 
postive band at ~280 nm, a negative band near 240 nm and a crossover near 255 nm.3 
 
Catalytic experiments, validation of workup procedure. 
To a solution of salmon testes DNA and in situ prepared copper complex from ligand 1a, at the 
typical concentrations described in the representative procedure for catalytic experiments, was 
added racemic Diels-Alder product 4a to a final concentration of 0.6 mM. The mixture was 
incubated for 5 h at room temperature or 3 h at room temperature followed by 3 nights at 5 °C, 
after which 4a was isolated by extraction following the standard work up procedure. In both 
cases no enantiomeric enrichment for both the endo and exo isomer was observed, as indicated 
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Scheme S1. Synthesis of the ligands 1. i. 2-pyridinecarboxaldehyde, MeOH; ii. NaBH4; iii. R-Cl, 
K2CO3, CH3CN, reflux; iv. TFA, thiophenol, CH2Cl2; v. 9-chloroacridine, phenol, 100 °C. 
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Reductive aminations (steps i & ii) 
 
tert-butyl 3-[(2-pyridinylmethyl)amino]propylcarbamate (5a), general procedure. 
To a solution of mono-Boc protected propanediamine (1.51 g, 8.6 mmol) in methanol (30 ml) 
was added freshly distilled 2-pyridinecarboxaldehyde (923 mg, 1 eq). After stirring for 1 h at 
room temperature, NaBH4 (314 mg, 8.6 mmol) was added in small portions. Stirring was 
continued for 1 h at room temperature, after which time the reaction was quenched by addition of 
sat. NH4Cl solnd (10 ml). The pH was brought to >7 using a 2M NaCO3 solution and the 
methanol was evaporated in vacuo. The aqueous phase was extracted with ethylacetate (3 × 20 
ml) and the combined organic layers were washed with brine (10 ml), dried (Na2SO4) and the 
solvent evaporated to give pure 5a (2.19 g, 8.3 mmol, 97 %) as a slightly yellow oil. 1H-NMR 
(CDCl3, 400 MHz) δ 1.44 (s, 9H), 1.71 (m, 2H), 2.73 (t, 2H, 6.6 Hz), 3.23 (m,  2H), 3.91 (s, 2H), 
7.17 (dd, ) 7.31 (d, 1H, J = 8.1 Hz), 7.65 (dd, 1H, J = ), 8.57 (d, 1H, 4.8 Hz); 13C-NMR (CDCl3, 
100 MHz) δ 28.14 (q), 29.43 (t), 38.57 (t), 46.73(t), 54.58 (t), 78.48 (s), 121.72 (d), 122.06 (d), 
136.25 (d), 148.88 (d), 155.89 (s), 159.05 (s); HRMS calcd. for C14H23N3O2: 265,1790, found: 
265.1781. 
 
tert-butyl 4-[(2-pyridinylmethyl)amino]butylcarbamate (5b) 
Starting from mono-Boc protected 1,4-diaminobutane (1.06 g, 5.6) mmol, 5b (1.53 g, 5.5 mmol, 
98 %) was obtained as a slightly yellow oil. 1H-NMR (CDCl3, 400 MHz) δ 136 (s, 9H), 1.48 (m, 
4H), 2.60 (t, 2H, J = 6.6 Hz), 3.05 (m, 2H), 3.82 (s, 2H), 7.09 (m, 1H), 7.23 (d, 1H, J = 8.4 hz), 
7.57 (m, 1H), 8.48 (d, 1H, J =  4.8 Hz); 13C-NMR (CDCl3, 100 MHz) δ 26.75 (t), 27.22 (t), 27.84 
(q), 39.76 (t), 48.50 (t), 54.46 (t), 77.89 (s), 121.26 (d), 121.61 (d), 135.78 (d), 148.55 (d), 155.53 
(s), 159.16 (s); MS (CI) 280 (M+1). 
 
tert-butyl 4-[(2-pyridinylmethyl)amino]butylcarbamate (5c) 
Starting from mono-Boc protected 1,5-diaminopentane (1.1 g, 5.4) mmol, 5c (1.58 g, 5.4 mmol, 
98 %) was obtained as a slightly yellow oil. 1H-NMR (CDCl3, 400 MHz) δ 1.35 (m, 2H), 1.41 (s, 
9H), 1.48 (m, 2H), 1.56 (m, 2H), 2.66 (t, 2H, J = 7.0 Hz), 3.08 (m, 2H), 3.91 (s, 2H), 7.15 (m, 
1H), 7.28 (d, 1H, J = 7.7 Hz), 7.63 (m, 1H), 8.54 (d, 1H, J = 4.8 Hz); 13C-NMR (CDCl3, 100 
MHz) δ 23.87 (t), 27.78 (q), 29.04 (t), 29.30 (t), 48.71 (t), 54.43 (t), 77.80 (s), 121.19 (d), 121.56 
(d), 135.71 (d), 148.48 (d), 155.47 (s), 159.12 (s); MS (CI) 294 (M+1). 
 
tert-butyl 2-[(2-pyridinylmethyl)amino]ethylcarbamate (5d) 
Starting from mono-Boc protected ethylene diamine (1.02 g, 6.3) mmol, 5d (1.38 g, 5.5 mmol, 87 
%) was obtained as a slightly yellow oil. 1H -NMR (CDCl3, 400 MHz) δ 1.44 (s, 9H), 2.81 (m, 
2H), 3.28 (m, 2H), 3.93 (s, 2H), 7.18 (m, 1H), 7.28 (d, 1H, J = 7.7 Hz), 7.64 (m, 1H), 8.56 (d, 1H, 
J = 4.0 Hz); 13C-NMR (CDCl3, 100 MHz) δ 28.19 (q), 40.01 (t), 48.49 (t), 54.26 (t), 78.80 (s), 
121.94 (d), 122.20 (d), 136.52 (d), 148.97 (d), 156.03 (s), 159.05 (s); MS (CI) 252 (M+1). 
 
Alkylations (step iii) 
 
tert-butyl 3-[(1-naphthylmethyl)(2-pyridinylmethyl)amino]propylcarbamate (6a), general 
procedure 
A solution of 5a (630 mg, 2.4 mmol), 1-chloromethylnaphtalene (548 mmol, 1.3 eq), K2CO3 (330 
mg, 2.4 mmol) in CH3CN was placed under nitrogen. After heating under reflux for 1 night the 
solvent was evaporated and the crude material redissolved in water (30 ml). Extraction with ethyl 
acetate (3×20 ml) was followed by washing the combined organic layers with brine. After drying 
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(Na2SO4) the ethyl acetate was evaporated and the crude material subjected to column 
chromatography (Alox, akt III, neutral, heptane: ethyl acetate: triethyl amine 20:10:1) which gave 
6a (701 mg, 1.73 mmol, 72 %) as a yellow oil. 1H-NMR (CDCl3, 400 MHz) δ 1.41 (s, 9H), 1.71 
(m, 2H), 2.59 (t, 2H, J = 6.6 Hz), 3.04 (m, 2H), 3.79 (s, 2H), 4.03 (s, 2H), 7.15 (m, 1H), 7.36 (d, 
1H, J = 7.7 Hz), 7.41 (m, 1H), 7.48 (m, 2H), 7.53 (d, 1H, J = 6.6 Hz), 7.61 (m, 1H), 7.75 (d, 1H, J 
= 8.4 Hz), 7.82 (m, 1H), 8.14 (m, 1H), 8.57 (m, 1H); 13C-NMR (CDCl3, 100 MHz) δ 26.48 (t), 
28.27 (q), 38.79 (t), 51.89 (t), 57.15 (t), 60.10 (t), 78.22 (s), 121.71 (d), 123.05 (d), 124.17 (d), 
124.96 (d), 125.34 (d), 125.48 (d), 127.18 (d), 127.70 (d), 128.22 (d), 132.00 (s), 133.54 (s), 
134.40 (s), 136.05 (d), 148.69(d), 155.81 (s), 159.33 (s); MS (CI) 406 (M+1). 
 
tert-butyl 4-[(1-naphthylmethyl)(2-pyridinylmethyl)amino]butylcarbamate (6b) 
Starting from 5b (751 mg, 2.7 mmol) after purification by column chromatography (Alox, akt III, 
neutral, heptane: ethyl acetate: triethyl amine 10:1:1) resulted in 6b (757 mg, 1.8 mmol, 67 %) as 
a colorless oil. 1H-NMR (CDCl3, 400 MHz) δ 1.37 (m, 2H), 1.40 (s, 9H), 1.56 (m, 2H), 2.53 (t, 
2H, J = 7.3 Hz), 2.95 (m, 2H), 3.75 (s, 2H), 4.04 (s, 2H), 7.08 (m, 1H), 7.37 (m, 2H), 7.45 (m, 
2H), 7.50 (d, 1H, 6.2 Hz), 7.54 (m, 1H), 7.72 (d, 1H, J = 8.4 Hz), 7.80 (m, 1H), 8.20 (m, 1H), 
8.46 (d, 1H, J = 4.4 Hz); 13C-NMR (CDCl3, 100 MHz) δ 23.66 (t), 27.48 (t), 28.11 (q), 39.86 (t), 
53.77 (t), 57.16 (t), 60.03 (t), 78.31 (s), 121.40 (d), 122.72 (d), 124.27 (d), 124.83 (d), 125.17 (d), 
125.21 (d), 126.98 (d), 127.48 (d), 128.05 (d), 132.01 (s), 133.44 (s), 134.61 (s), 135. 81 (d), 
148.28 (d), 15.68 (s), 159.82 (s); MS (CI) 420 (M+1). 
 
tert-butyl 5-[(1-naphthylmethyl)(2-pyridinylmethyl)amino]pentylcarbamate (6c) 
Starting from 5c (964 mg, 3.3 mmol) after column chromatography (Alox, akt III, neutral, 
heptane: ethyl acetate: triethyl amine 10:1:1) 6c (997 mg, 2.3 mmol, 70 %) as a colorless oil1H-
NMR (CDCl3, 400 MHz) δ 1.27 (m, 4H), 1.41 (s, 9H), 1.55 (m, 2H), 2.51 (t, 2H, J = 7.0 Hz), 
2.98 (m, 2H), 3.75 (s, 2H), 4.03 (s, 2H), 7.07 (m, 1H), 7.37 (m, 2H), 7.37 (m, 2H), 7.51 (d, 1H, J 
= 7.0 Hz), 7.55 (m, 1H), 7.72 (d, 1H, J = 8.1 Hz), 7.81 (m, 1H), 8.22 (m, 1H), 8.46 (d, 1H, J = 4.0 
Hz); 13C-NMR (CDCl3, 100 MHz) δ 24.10 (t), 26.11 (t), 28.09 (q), 29.32 (t), 40.05 (t), 53.92 (t), 
57.18 (t), 60.10 (t), 78.28 (s), 121.33 (d), 122.68 (d), 124.31 (d), 124.80 (d), 125.13 (d), 125.14 
(d), 132.02 (s), 133.43 (s), 134.69 (s), 135.75 (d), 148.20 (d), 155.63 (s), 159.95 (s); MS (CI) 434 
(M+1). 
 
tert-butyl 2-[(1-naphthylmethyl)(2-pyridinylmethyl)amino]ethylcarbamate (6d) 
Starting from 5d (498 mg, 2.0 mmol) after column chromatography (Alox, akt III, neutral, 
heptane: ethyl acetate: triethyl amine 20:10:1) 6d (573 mg, 1.46 mmol, 73 %) was obtained as a 
slightly yellow oil. (1H-NMR (CDCl3, 400 MHz) δ 1.34 (s, 9H), 2.68 (t, 2H, J = 5.9 Hz), 3.20 (m, 
1H), 3.81 (s, 2H), 4.10 (s, 2H), 7.11 (m, 1H), 7.24 (d, 1H, J = 7.3 Hz), 7.37 (m, 1H), 7.46 (m, 
2H), 7.56 (m, 1H), 7.73 (d, 1H, J = 8.1 Hz), 7.81 (m, 1H), 8.14 (m, 1H), 8.51 (d, 1H, J = 4.0 Hz); 
13C-NMR (CDCl3, 100 MHz) δ 28.11 (q), 37.93 (t), 53.22 (t), 57.39 (t), 59.80 (t), 78.17 (s) 
121.60 (d), 122.91 (d), 124.14 (d), 124.82 (d), 125.28 (d), 125.43 (d),  127.32 (d), 127.32 (d), 
127.76 (d), 128.16 (d), 131.96 (s), 133.53 (s), 134.18 (s), 135.84 (d), 148.53 (d), 155.66 (s), 
159.10 (s); MS (CI) 392 (M+1). 
 
tert-butyl 3-[(3,5-dimethoxybenzyl)(2-pyridinylmethyl)amino]propylcarbamate (6e) 
Starting from 5a (687 mg, 2.6 mmol) and 3,5-dimethoxybenzyl chloride (1.3 eq) after column 
chromatography (Alox, akt III, neutral, heptane: ethyl acetate: triethyl amine 20:10:1) 6e (622 
mg, 1.5 mmol, 58 %) was obtained as a slightly yellow oil. 1H-NMR (CDCl3, 400 MHz) δ 1.41 
(s, 9H), 1.68 (m, 2H), 2.53 (t, 2H, J = 6.6 Hz), 3.15 (m, 2H), 3.50 (s, 2H), 3.70 (s, 2H), 3.75 (s, 
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6H), 6.31 (s, 1H), 6.52 (s, 2H), 7.13 (m, 1H), 7.40 (d, 1H, J = 7.3 Hz) 7.62 (m, 1H), 8.54 (d, 1H, J 
= 4.4 Hz); 13C-NMR (CDCl3, 100 MHz) δ 26.44 (t), 28.28 (q), 38.95 (t), 51.68 (t), 55.01 (q), 
58.67 (t), 59.73 (t), 78.35 (s), 98.73 (d), 106.32 (d), 121.78 (d), 136.26 (d) 141.49 (s), 148.83 (d), 
155.94 (s), 159. 38 (s), 160.56 (s);  MS (CI) 416 (M+1). 
 
tert-butyl 2-[(3,5-dimethoxybenzyl)(2-pyridinylmethyl)amino]ethylcarbamate (6f) 
Starting from 5d (248 mg, 1.0 mmol) and 3,5-dimethoxybenzyl chloride (1.3 eq) after column 
chromatography (Alox, akt III, neutral, heptane: ethyl acetate: triethyl amine 20:10:1) 6f (335 
mg, 0.84 mmol, 84 %) was obtained as a slightly yellow oil. 1H-NMR (CDCl3, 400 MHz) δ 1.40 
(s, 9H), 2.61 (t, 2H, J = 5.9 Hz), 3.20 (m, 2H), 3.59 (s, 2H), 3.78 (s, 2H), 3.78 (s, 6H), 6.32 (s, 
1H), 6.51 (s, 2H), 7.13 (m, 1H), 7.37 (d, 1H, J = 7.7 Hz), 7.62 (m, 1H), 8.51 (d, 1H, J = 4.8 Hz); 
13C-NMR (CDCl3, 100 MHz) δ 28.09 (q), 37.92 (t), 52.86 (t), 54.83 (q), 58.48 (t), 59.53 (t), 78.29 
(s), 98.79 (d), 106.11 (d), 121.68 (d), 122.60 (d), 136.05 (d), 141.34 (s), 148.62 (d), 155.72 (s), 
159.22 (s), 160.48 (s); MS (CI) 402 (M+1). 
 
Deprotection (step iv). 
 
N1-(1-naphthylmethyl)-N1-(2-pyridinylmethyl)-1,3-propanediamine (7a) 
To a solution of 6a (670 mg, 1.65 mmol) in CH2Cl2 (9 ml) was added thiophenol (1 ml) and 
trifluoroacetic acid (1 ml). After stirring for 6 h at room temperature a 1 M HCl solution (10 ml) 
was added. The CH2Cl2 was evaporated and the aqueous layer was extracted with diethyl ether 
(3×70 ml). The pH of the aqueous phase was brought to >10 by addition of 2 M NaOH. 
Extraction with CH2Cl2 (3×30 ml) was followed by washing of the combined organic layers with 
brine. After drying the solvent was removed in vacuo to give pure 7a (291 mg, 0.95 mmol, 58 %) 
as a slightly yellow oil. 1H-NMR (CDCl3, 400 MHz) δ 1.73 (m, 2H), 2.61 (t, 2H, J = 7.0 Hz), 
2.66 (t, 2H, J = 6.6 Hz), 3.79 (s, 2H), 4.06 (s, 2H), 7.12 (m, 1H), 7.37 (d, 1H. J = 7.3 Hz), 7.41 
(m, 1H), 7.48 (m, 2H), 7.54 (d, 1H, J = 7.0 Hz), 7.58 (m, 1H), 7.75 (d, 1H, J = 8.1 Hz), 7.83 (m, 
1H), 8.21 (m, 1H), 8.52 (d, 1H, J = 4.8 Hz); 13C-NMR (CDCl3, 100 MHz) δ 30.20 (t), 39.83 (t), 
51.61 (t), 57.13 (t), 60.11 (t), 121.48 (d), 122.74 (d), 124.17 (d), 124.84 (d), 125.21 (d), 125.24 
(d), 127.01 (d), 127.94 (d), 128.07 (d), 131.94 (s), 133.41 (s), 134.55 (s), 135.89 (d), 148.32 (d), 
159.72 (s); HRMS calcd. for C20H23N3: 305.1892, found: 305.1897. 
 
N1-(1-naphthylmethyl)-N1-(2-pyridinylmethyl)-1,4-butanediamine (7b) 
Starting from 6b (750 mg, 1.79 mmol) after reacting overnight at room temperature, 7b (514 mg, 
1.61 mmol, 90 %) was obtained as a nearly colorless oil. 1H-NMR (CDCl3, 400 MHz) δ 1.34 (m, 
2H), 1.58 (m, 2H), 2.52 (m, 4H), 3.76 (s, 2H), 4.04 (2H), 7.07 (m, 1H), 7.37 (m, 2H), 7.45 (m, 
2H), 7.53 (m, 2H), 7.72 (d, 1H, J = 8.4 Hz), 7.80 (m, 1H), 7.23 (m, 1H), 8.46 (d, 1H, J = 4.0 Hz); 
13C-NMR (CDCl3, 100 MHz) δ 23.52 (t), 30.74 (t), 41.22 (t), 53.79 (t), 56.93 (t), 59.83 (t), 
121.20 (d), 122.52 (d), 124.09 (d), 124.65 (d), 124.97 (d), 124.99 (d), 126.76 (d), 127.25 (d), 




Starting from 6c (978 mg, 2.25 mmol) after reacting overnight at room temperature, using 1.5 
times as much TFA as in the general procedure, resulted in 7c (724 mg, 2.17 mmol, 97 %) was 
obtained as a nearly colorless oil.1H-NMR (CDCl3, 400 MHz) δ 1.24 (m, 4H), 1.57 (m, 2H), 2.54 
(m, 4H), 3.76 (s, 2H), 4.04 (s, 2H), 7.06 (m, 1H), 7.37 (m, 2H), 7.45 (m, 2H), 7.53 (m, 2H), 7.72 
(d, 1H, J = 8.4 Hz), 7.80 (m, 1H), 8.24 (m, 1H), 8.45 (m, 1H); 13C-NMR (CDCl3, 100 MHz) δ 
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23.91 (t), 26.05 (t), 32.93 (t), 41.50 (t), 53.82 (t), 56.94 (t), 59.94 (t), 121.03 (d), 122.38 (d), 
124.09 (d), 124.56 (d), 124.87 (d, 2 overlapping signals), 126.73 (d), 127.14 (d), 127.75 (d), 
131.80 (s), 133.18 (s), 134.53 (s), 135.42 (d), 147.99 (d), 159.79 (s); MS (CI) 334 (M+1). 
 
N1-(1-naphthylmethyl)-N1-(2-pyridinylmethyl)-1,2-ethanediamine (7d) 
Starting from 6d (565 mg, 1.45 mmol) 7d (345 mg, 1.19 mmol, 82 %) was obtained as a slightly 
yellow oil. 1H-NMR (CDCl3, 400 MHz) δ 2.68 (t, 2H, J = 5.9 Hz), 2.78 (t, 2H, J = 5.9 Hz), 3.80 
(s, 2H), 4.10 (s, 2H), 7.09 (m, 1H), 7.27 (d, 1H, J = 8.1 Hz), 7.37 (m, 1H), 7.45 (m, 2H), 7.50 (d, 
1H, J = 7.0 Hz), 7.54 (m, 1H), 7.73 (d, 1H, J = 8.1 Hz), 7.80 (m, 1H), 8.17 (m, 1H), 8.48 (d, 1H, J 
= 4.0 Hz); 13C-NMR (CDCl3, 100 MHz) δ 39.21 (t), 57.21 (t), 57.57 (t), 60.34 (t), 121.43 (d), 
122.73 (d), 124.06 (d), 124.76 (d), 125.16 (d), 125.25 (d), 127.21 (d), 127.56 (d), 128.05 (d), 
131.92 (s), 133.40 (s), 134.39 (s), 135.74 (d), 148.36 (d), 159.47 (s). 
 
N1-(3,5-dimethoxybenzyl)-N1-(2-pyridinylmethyl)-1,3-propanediamine (7e) 
Starting from 6e (557 mg, 1.34 mmol) 7e (279 mg, 0.89 mmol, 66 %) was obtained as a slightly 
yellow oil. 1H-NMR (CDCl3, 400 MHz) δ 1.66 (m, 2H), 2.53 (t, 2H, J = 7.0 Hz), 2.73 (t, 2H, J = 
7 Hz), 3.56 (s, 2H), 3.73 (s, 2H), 3.78 (s, 6H), 6.33 4 (s, 1H), 6.56 (s, 2H), 7.14 (m, 1H), 7.52 (d, 
1H, J = 8.1 Hz), 7.64 (m, 1H), 8.50 (d, 1H, J = 4.0 Hz); 13C-NMR (CDCl3, 100 MHz) δ 30.57 (t), 
39.83 (t), 50.94 (t), 54.73 (q), 58.40 (t), 59.77 (t), 98.29 (d), 106.02 (d), 121.39 (d), 122.22 (d), 
135.88 (d), 141.67 (s), 148.38 (d), 159.78 (s), 160.26 (s); HRMS calcd. for C18H25N3O2 
315.1947, found 315.2008. 
 
N1-(3,5-dimethoxybenzyl)-N1-(2-pyridinylmethyl)-1,2-ethanediamine (7f) 
Starting from 6f (565 mg, 1.4 mmol) 7f (345 mg, 1.15 mmol, 82 %) was obtained as a slightly 
yellow oil. 1H-NMR (CDCl3, 400 MHz) δ 2.59 (t, 2H, J = 5.9 Hz), 2.77 (t, 2H, J = 5.9 Hz), 3.59 
(s, 2H), 3.75 (s, 2H), 3.76 (s, 6H), 6.32 (s, 1H), 6.52 (s, 2H), 7.13 (m, 1H), 7.47 (d, 1H, J = 7.7 
Hz), 7.63 (m, 1H), 8.50 (d, 1H, J = 4.0 Hz); 13C-NMR (CDCl3, 100 MHz) δ 39.26 (t), 54.84 (q), 
56.82 (t), 58.79 (t), 60.06 (t), 98.41 (d), 106.28 (d), 121.56 (d), 122.45 (d), 135.98 (d), 141.51 (s), 
148.52 (d), 159.59 (s), 160.37 (s); HRMS calcd. For C17H23N3O2: 301.1790, found 301.1784. 
 
Coupling to acridine (step v). 
 
N1-(9-acridinyl)-N3-(1-naphthylmethyl)-N3-(2-pyridinylmethyl)-1,3-propanediamine (1a) 
A mixture of 7a (285 mg, 0.93 mmol), 9-chloroacridine (200 mg, 1 eq) and phenol (1 g) was 
placed under nitrogen and heated at 100 °C for 2h. After cooling to room temperature diethyl 
ether (50 ml) was added and the mixture was stirred for 1h. The diethyl ether was decanted from 
the dark oil, and fresh diethyl ether (50 ml) was added. After stirring for 2 days the hydrochloride 
salt of 1a (437 mg, 0.84 mmol, 91 %) was isolated as a yellow solid. Dissolving a small amount 
in 1 M NaOH, followed by extraction with CH2Cl2 gave the free base as a dark yellow oil, which 
was used for analysis. 1H-NMR (CDCl3, 400 MHz) δ 1.88 (m, 2H), 2.71 (t, 2H, J = 6.2 Hz), 3.68 
(t, 2H, J = 6.2 Hz), 3.80 (s, 2H), 4.04 (s, 2H), 7.02 (m, 1H), 7.16 (m, 3H), 7.32 (m, 3H), 7.41 (m, 
1H), 7.46 (m, 1H), 7.57 (m, 2H), 7.68 (d, 1H, J = 8.1 Hz), 7.73 (d, 1H, J = 7.7 Hz), 7.82 (d, 2H, J 
= 8.4 Hz), 8.00 (d, 2H, J = 8.8 Hz), 8.16 (d, 1H, J = 8.1 Hz), 8.43 (d, 1H, J = 4.8 Hz); HRMS 
calcd. for C33H30N4: 482.2470, found: 482.2477 
 
N1-(9-acridinyl)-N4-(1-naphthylmethyl)-N4-(2-pyridinylmethyl)-1,4-butanediamine (1b) 
Starting from 7b (510 mg, 1.6 mmol) resulted in the hydrochloride salt of 1b (690 mg, 1.29 
mmol, 81 %) as a yellow solid. Treatment with base resulted in the free base that was used for 
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further characterisation. 1H-NMR (CDCl3, 400 MHz) δ 1.62 (m, 4H), 2.46 (t, 2H, J = 6.6 Hz), 
3.54 (t, 2H, J = 6.6 Hz), 3.77 (s, 2H), 4.02 (s, 2H), 7.06 (m, 1H), 7.31 (m, 3H), 7.33 (d, 1H, J = 
8.1 Hz), 7.38 (m, 2H), 7.48 (m, 2H), 7.64 (m, 2H), 7.67 (d, 1H, J = 8.1 Hz), 7.75 (m, 1H), 7.95 
(dd, 2H, J = 8.8 Hz, J = 0.7 Hz), 8.05 (d, 2H, J = 8.4 Hz), 8.15 (m, 1H), 8.46 (m, 1H); HRMS 
calcd. For C34H32N4: 496.2627, found: 496.2650. 
 
N1-(9-acridinyl)-N5-(1-naphthylmethyl)-N5-(2-pyridinylmethyl)-1,5-pentanediamine (1c) 
Starting from 7c (720 mg, 2.16 mmol) resulted in the hydrochloride salt of 1c (970 mg, 1,77 
mmol, 82 %) as a yellow solid. Treatment with base resulted in the free base that was used for 
further characterisation. 1H-NMR (CDCl3, 400 MHz) δ 1.32 (m, 2H), 1.43 (m, 2H), 1.54 (m, 2H), 
2.52 (t, 2H, J = 7.0 Hz), 3.54 (t, 2H, J= 7.3 Hz), 3.76 (s, 2H), 4.01 (s, 2H), 7.05 (m, 1H), 7.2-7.4 
(m, 6H), 7.49 (m, 2H), 7.66 (m, 3H), 7.70 (d, 1H, J = 8.4 Hz), 7.97 (d, 2H, J = 8.8 Hz), 8.06 (d, 




Starting from 7d (340 mg, 1.16 mmol) resulted in the hydrochloride salt of 1d (563 mg, 1.11 
mmol, 96 %) as a yellow solid. Treatment with base resulted in the free base that was used for 
further characterisation. 1H-NMR (CDCl3, 400 MHz) δ 2.99 (t, 2H, J = 5.5 Hz), 3.90 (s, 2H), 3.92 
(m, 2H), 4.15 (s, 2H), 7.08 (m, 2H), 7.15 (d, 1H, J = 7.7 Hz), 7.21 (m, 1H), 7.31 (m, 1H), 7.45 
(m, 4H), 7.54 (m, 2H), 7.71 (d, 1H, J = 8.1 Hz), 7.78 (d, 1H, J = 8.1 Hz), 7.86 (d, 2H, J = 8.8 Hz), 
7.96 (d, 2H, J = 8.4 Hz), 8.05 (d, 1H, J = 8.4 Hz), 8.48 (d, 1H, J = 4.7 Hz); HRMS calcd. For 
C32H28N4: 468.2314, found: 468.2337. 
 
N1-(9-acridinyl)-N3-(3,5-dimethoxybenzyl)-N3-(2-pyridinylmethyl)-1,3-propanediamine (1e) 
Starting from 7e (275 mg, 0.87 mmol) resulted in the hydrochloride salt of 1e (361 mg, 0.68 
mmol, 78 %) as a yellow solid. Treatment with base resulted in the free base that was used for 
further characterisation. 1H-NMR (CDCl3, 400 MHz) δ 1.95 (m, 2H), 2.73 (t, 2H, J = 6.2 Hz), 
3.64 (s, 2H), 3.66 (2, 6H), 3.82 (s, 2H), 3.91 (t, 2H, J = 6.2 Hz), 6.33 (s, 1H), 6.56 (s, 2H), 7.09 
(m, 1H), 7.26 (t, 2H, J = 6.6 Hz), 7.35 (d, 1H, J = 7.7 Hz), 7.52 (m, 1H), 7.64 (m, 2H), 8.04 (d, 
4H, J = 9.5 Hz), 8.48 (m, 1H); MS (EI) 492 (M+). 
 
N1-(9-acridinyl)-N2-(3,5-dimethoxybenzyl)-N2-(2-pyridinylmethyl)-1,2-ethanediamine (1f) 
Starting from 7f (540 mg, 1.8 mmol) resulted in the hydrochloride salt of 1f (903 mg, 1.75 mmol, 
97 % %) as a yellow solid. Treatment with base resulted in the free base that was used for further 
characterisation. 1H-NMR (CDCl3, 400 MHz) δ 2.96 (t, 2H, J = 5.5 Hz),3.64 (s, 6H), 3.68 (s, 
2H), 3.86 (s, 2H), 3.97 (t, 2H, J = 5.5 Hz), 6.32 (s, 1H), 6.52 (s, 2H), 7.12 (m, 1H), 7.27 (m, 3H), 
7.55 (m, 1H), 7.62 (m, 2H), 8.02 (d, 2H, J = 8.4 Hz), 8.24 (d, 2H, 8.4 Hz), 8.53 (d, 1H, J = 5.1 
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